outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,59128.197006,8253.0010417,423620.89421,0,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2817,708,0.1866260932,0.0542245269,0.6423163219,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,700,533,1.5687980397,0.7196055578,3.4201060048,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.3036729858,0.0340277416,2.7100617915,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.3162567454,0.1132644176,0.8830516332,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,700,1906,1.7486222574,1.012713619,3.01929365,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,35152.259984,4871.1665555,253672.57881,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2817,708,0.1897572298,0.0506983058,0.7102368754,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,700,533,1.5750749211,0.6968948081,3.5598787339,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.2489338922,0.0276759415,2.2390596057,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2307224016,0.0728340472,0.7308783278,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,700,1906,1.7980047266,1.0037457764,3.2207567622,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,14361.812276,1986.5838147,103827.30913,0,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,708,0.2005405206,0.053652932,0.7495676171,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,700,533,1.7490995659,0.7740699147,3.9522906564,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,0.2451747491,0.0272372137,2.2069312364,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2266127704,0.0711417775,0.7218451593,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,700,1906,1.7486755403,0.9711496942,3.1487073141,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,35065.916408,4856.3904046,253195.97295,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2817,708,0.1820061456,0.0488544271,0.6780600867,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,700,533,1.4932360629,0.6570002214,3.3938404692,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,0.2454125867,0.0272940923,2.2066070942,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2312502899,0.0730344001,0.7322124433,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,700,1906,1.7937417213,1.0011289366,3.2138810949,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,35131.984158,4867.1604759,253588.57941,0,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2817,708,0.1875366725,0.0501070073,0.7018979071,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,700,533,1.5201996993,0.677755959,3.4097924113,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,0.249609555,0.0277504993,2.245182303,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2318123853,0.0731698974,0.7344137948,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,700,1906,1.7883268099,0.9993365176,3.2002360793,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,38820.55397,5364.6667765,280918.73612,0,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2817,708,0.1918430089,0.0514498996,0.7153316207,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,700,533,1.6278799234,0.7185610505,3.6879163474,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,0.2406698294,0.0267586049,2.1646108588,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2272870535,0.0713849977,0.7236731294,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,700,1906,1.743275567,0.9710329147,3.1296670345,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,23174.417322,3219.1720791,166829.73293,0,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,708,0.1999869128,0.0539449547,0.7413995521,1,1
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,700,533,1.7687159536,0.7827817346,3.9964602986,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,0.2434146329,0.0270181669,2.1929942084,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.224242361,0.0705818064,0.7124305688,1,1
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,700,1906,1.7447757485,0.9688754945,3.1420367526,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,1.1021763525,0.2416574559,5.0269200572,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.6199713563,0.3154155396,1.2185971658,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,702,537,1.1988248333,0.8023506116,1.7912131681,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.2035901807,0.5016058683,2.8879832046,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2566667454,0.7476845235,2.1121358798,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,1.0441900373,0.8076392269,1.3500246121,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,1.7995601159,0.3691863193,8.7717676448,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.6764060228,0.3148818095,1.4530058383,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,702,537,1.1896629896,0.7613145782,1.8590186886,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,2.3367396474,0.884297038,6.1747941527,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.295241729,0.6878261908,2.4390625992,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,1.0162206897,0.7553390123,1.3672066097,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,1.9397769085,0.3992561058,9.4243629594,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.7235630464,0.3344199563,1.5655270337,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,1.2987105734,0.8370759484,2.0149296569,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,2.3026809748,0.8705893572,6.0905174496,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2883168294,0.6816753251,2.4348251898,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,0.9970635121,0.7404805239,1.3425547534,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,1.7881338839,0.3670035461,8.7122394894,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,0.6239197408,0.2907292896,1.3389632791,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,702,537,1.0767748975,0.6897669362,1.680921655,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,2.2881514685,0.864525427,6.0560823078,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.3018888118,0.6914937777,2.4510914385,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,702,1920,1.0169736555,0.7539600188,1.3717377449,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,1.8224629686,0.3737411227,8.886823177,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.6857851719,0.3192147936,1.4733067244,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,702,537,1.2314038098,0.7784185574,1.9479948523,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,2.3294636099,0.881457836,6.1561659429,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2890728948,0.6847391541,2.4267765588,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,1.025180764,0.759535553,1.383734566,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,1.9610262725,0.4040074655,9.5186954929,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.6813284849,0.3153931585,1.4718407547,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,702,537,1.2143489421,0.77722899,1.8973087367,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,2.2376472962,0.8449591628,5.9258075924,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2880676273,0.6825022292,2.430934496,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,1.0121491726,0.7484791282,1.3687034266,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,1.89031992,0.3898440233,9.1659976452,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.7140612918,0.3303316803,1.5435501914,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,1.2876242289,0.8277954814,2.0028813784,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,2.2781425438,0.8612539962,6.0260195867,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2754032762,0.6749579819,2.4100070828,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,0.9935300479,0.7371819756,1.3390207422,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,530,136,0.75237939,0.2084023215,2.7162593124,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2791,683,0.6507917822,0.3667201286,1.1549132726,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,647,474,0.8007600159,0.5676650146,1.129568648,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,530,658,0.3864995024,0.1901782299,0.7854835195,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.5921253992,0.4163714234,0.8420666467,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,647,1814,0.6493758767,0.5050995403,0.8348632213,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,530,136,0.8861918059,0.2315090425,3.3922472679,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2791,683,0.8728174127,0.4194004845,1.8164266948,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,647,474,0.9294077086,0.6388077793,1.3522043981,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,530,658,0.380093887,0.1727984232,0.8360687571,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7277631551,0.4615577954,1.1475035525,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,647,1814,0.7501328258,0.5644848574,0.9968367599,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,530,136,0.8815637176,0.2294777958,3.3866221577,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2791,683,0.8718374128,0.4202770251,1.8085701309,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,647,474,0.9286885007,0.6423518508,1.3426634177,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,530,658,0.3811368315,0.1733331957,0.8380696137,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7307581532,0.462205434,1.1553466039,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,647,1814,0.7515194361,0.5642900771,1.0008708036,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,530,136,0.8857954292,0.2311698663,3.3941860809,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2791,683,0.8341546106,0.40084255,1.7358783749,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,647,474,0.8656277439,0.5947242765,1.2599307288,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,530,658,0.37487317,0.1701793639,0.8257751723,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7295473751,0.4628810065,1.1498405963,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,647,1814,0.7490990187,0.5635438537,0.9957509713,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,530,136,0.8784547812,0.2294754987,3.3628113106,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2791,683,0.8697527336,0.4182622818,1.8086015656,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,647,474,0.9101687154,0.6251996264,1.3250281278,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,530,658,0.3807668408,0.1730980727,0.8375794417,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7305668943,0.4633327166,1.1519324406,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,647,1814,0.7487650158,0.5635724691,0.9948126986,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,530,136,0.8827974854,0.2294951501,3.3958512845,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2791,683,0.8355267896,0.4027903036,1.733172348,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,647,474,0.8545426496,0.589654812,1.2384247955,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,530,658,0.3757078429,0.1706348002,0.8272426437,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.733053445,0.4639018448,1.1583643377,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,647,1814,0.7485039908,0.5623609365,0.9962609203,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,530,136,0.8691738187,0.2256409903,3.3480757459,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2791,683,0.8634677553,0.4172454585,1.7869015689,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,647,474,0.9269374252,0.6397431954,1.3430592094,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,530,658,0.3799577941,0.1728234662,0.8353490901,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7293548218,0.4596963934,1.1571951917,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,647,1814,0.7485207064,0.5614139525,0.9979859698,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,533,139,1.1203789632,0.1310880791,9.5756153375,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2801,705,0.5914806213,0.2365613891,1.4788944496,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,672,511,1.2541072146,0.8117630113,1.9374926966,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,533,662,0.5443263893,0.1891226675,1.5666615857,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.7845312341,0.4190150018,1.468895516,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,672,1875,0.8351251577,0.6207585274,1.1235190468,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,MPCD,533,139,3.9768985748,0.4028970661,39.2549949,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2801,705,1.1064629968,0.4017090306,3.0476296777,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Medicare,672,511,1.2836774195,0.7995783729,2.0608707956,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,533,662,1.6578170137,0.4302725486,6.3874798891,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8175429045,0.3678455722,1.8170027074,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,672,1875,0.9351441273,0.6728933205,1.2996035363,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,533,139,3.9209361543,0.3990306161,38.527721193,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2801,705,1.0988953958,0.3998602603,3.0199827559,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,672,511,1.2727686984,0.7978368842,2.0304152285,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,533,662,1.6657991477,0.4311963886,6.4353201323,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8243076376,0.3693351809,1.8397464326,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,672,1875,0.9402757585,0.6724955795,1.3146829941,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,533,139,3.9589595057,0.40237773,38.951858412,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2801,705,1.048666844,0.3817963911,2.8803366801,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,672,511,1.1977304115,0.7453105967,1.9247789378,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,533,662,1.6247321206,0.4223044313,6.2508329737,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8208143359,0.3695613479,1.8230699121,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,672,1875,0.9327270795,0.670748133,1.2970290367,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,533,139,3.9796110217,0.4031605594,39.282870098,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2801,705,1.1072154354,0.4019929692,3.0496205517,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,672,511,1.2869337476,0.8005475329,2.0688321463,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,533,662,1.6575243958,0.4301885139,6.3864725209,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8173114149,0.3674138308,1.8181077927,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,672,1875,0.9357190146,0.6735451532,1.2999426543,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,533,139,3.9390779438,0.4019093622,38.606552884,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2801,705,1.0459853021,0.3815221866,2.867684477,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,672,511,1.1951521356,0.7460011191,1.914727191,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,533,662,1.62985857,0.4225306728,6.2869730625,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8254016571,0.3700195085,1.8412215568,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,672,1875,0.9371887261,0.6708776995,1.3092143456,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,533,139,3.66797315,0.3782571556,35.568466663,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2801,705,1.0500957209,0.3850186809,2.8640195339,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,672,511,1.2309248516,0.7686404786,1.9712414745,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,533,662,1.6515696471,0.4306465707,6.3339231857,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8152245625,0.3663348905,1.8141626817,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,672,1875,0.9438789502,0.6742784096,1.321275396,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,34928.067918,8667.9253373,140745.32037,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2805,704,1.0230173421,0.3526873204,2.9674003626,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,680,518,0.9377628605,0.6102437431,1.4410621861,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.2666100233,0.0578808631,1.2280553673,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.5282326776,0.3094025723,0.9018340072,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,680,1881,0.7844862553,0.5740772532,1.0720137077,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,17805.942462,4195.038485,75577.75408,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2805,704,1.6307944001,0.4906845468,5.4199595088,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Medicare,680,518,1.0314973449,0.6351297891,1.6752273171,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.1804317807,0.0373554023,0.8715105577,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9630146674,0.453361018,2.045604304,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,680,1881,0.843133316,0.5810525547,1.2234242544,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,18147.341669,4263.7132627,77239.248831,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2805,704,1.6574886887,0.502121705,5.4713204498,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,680,518,1.0543163276,0.6588271135,1.6872148944,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,0.1798303823,0.0372360257,0.8684859843,1,1
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.960319056,0.4492383168,2.0528362225,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,680,1881,0.8383607754,0.5726919577,1.2272719744,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,17863.038365,4190.6292084,76143.2529,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2805,704,1.5311379762,0.4597420656,5.0993452145,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,680,518,0.954854873,0.5890855158,1.5477342492,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,0.1769108181,0.0365232031,0.8569192987,1,1
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9655283465,0.4550318358,2.0487467347,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,680,1881,0.8387292681,0.5782767772,1.2164880431,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,6820.5480587,1606.9822749,28948.592991,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2805,704,1.6577173176,0.4972840089,5.5260709288,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,680,518,1.0680664732,0.6520832633,1.7494176822,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,0.1797275958,0.0372075091,0.8681583218,1,1
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9568425629,0.4520647669,2.0252577886,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,680,1881,0.8484740541,0.5842721339,1.2321453971,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,6947.038727,1626.5018151,29671.867947,0,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2805,704,1.5898608075,0.4793875496,5.272680505,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,680,518,1.0097492774,0.6274843887,1.6248907887,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,0.1754928425,0.0362382998,0.8498670739,1,1
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9583414326,0.450602971,2.0381985039,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,680,1881,0.8389015074,0.5739950781,1.2260658076,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,23469.443842,5501.2056095,100126.19658,0,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2805,704,1.5894586426,0.4904564777,5.1510763779,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,680,518,1.0330527365,0.6421883809,1.6618144895,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,0.1778788576,0.0368506625,0.8586246705,1,1
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9428442848,0.4469270076,1.9890392174,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,680,1881,0.835183843,0.5691473593,1.2255737293,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,455325.48897,144991.09969,1429889.8439,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2817,709,1.4611146009,0.1827173112,11.683927831,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,695,530,0.9278194773,0.4778861147,1.8013684766,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,442275.37303,142646.59382,1371273.5814,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.9237878155,0.3353543155,2.544723263,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,695,1908,0.8325041057,0.5099596557,1.3590547375,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,805246.68268,233737.15133,2774151.2904,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2817,709,0.6661926578,0.0823662626,5.3882820895,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Medicare,695,530,1.3828287452,0.671448338,2.8478964507,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,778249.43757,226743.34762,2671179.5227,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7945022901,0.277598297,2.2739112448,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,695,1908,1.1068888191,0.6286905268,1.9488171138,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,811842.02739,237214.23496,2778448.256,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,709,0.6671330297,0.0815022467,5.4607878562,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,695,530,1.4272729931,0.7045836339,2.8912227007,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,800622.09092,232190.7398,2760642.9655,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7935833681,0.2777332498,2.2675519137,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,695,1908,1.1054644073,0.6184318551,1.9760488495,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,801314.38626,230239.81397,2788851.9129,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2817,709,0.6305164273,0.078288474,5.0780267457,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,695,530,1.2801534302,0.6214129188,2.6372042731,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,767464.92423,220914.27995,2666203.4254,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7974887593,0.2787586909,2.2815013195,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,695,1908,1.100599482,0.62434771,1.9401356014,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,976814.85275,283517.77965,3365458.2712,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2817,709,0.689995528,0.0850969367,5.5947234635,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,695,530,1.503507188,0.7011050859,3.2242439968,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1078840.2785,314311.32792,3703004.77,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7818905931,0.2728376775,2.2407202154,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,695,1908,1.1271203383,0.6355915822,1.9987682224,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,974705.77149,283142.6508,3355380.5415,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2817,709,0.6598769178,0.0805807284,5.4037429985,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,695,530,1.421253776,0.6809464253,2.966404141,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1101822.8546,315553.49097,3847251.3775,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7876150568,0.2754732992,2.2518969333,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,695,1908,1.1196932925,0.6211305615,2.0184372611,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,1103186.8872,334909.06157,3633885.8745,0,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,709,0.6401671837,0.077702949,5.2741115784,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,695,530,1.4016849558,0.6893640015,2.8500483213,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,1116415.3004,326144.91558,3821562.3286,0,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7839644664,0.2752282478,2.2330567067,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,695,1908,1.1061172835,0.6185303389,1.9780686054,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,4.7054154186,0.6369659593,34.759996102,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.9032975039,0.6413950327,1.2721432798,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,702,537,0.872511524,0.6919636907,1.100168072,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.4988345438,0.7920976836,2.8361463949,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1551706578,0.9321710894,1.4315175228,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,0.9370953089,0.788202225,1.1141146144,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,13.186985674,1.6779132652,103.63860562,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.7670006694,0.4994125081,1.1779641424,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,702,537,0.9150626583,0.7103421143,1.1787836477,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,3.7076947348,1.630595142,8.4306642968,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1431353521,0.8853437214,1.4759899479,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,0.9652086937,0.7943025487,1.1728878672,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,14.047758512,1.7911758749,110.17316724,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.8032496851,0.5205880038,1.2393871007,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,0.9917751788,0.7749091782,1.2693332753,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,3.6617647038,1.6065631649,8.3460899883,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1300222513,0.8728410228,1.4629815224,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,0.9376605329,0.7709667896,1.140395782,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,13.186263712,1.6781428474,103.61308094,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,0.7685734389,0.4990827666,1.1835815029,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,702,537,0.9172860723,0.7120818116,1.1816250952,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,3.70937693,1.630708041,8.4377318705,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1430171058,0.8852825071,1.4757866485,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,702,1920,0.9653755841,0.7945217691,1.172969772,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,13.566447289,1.7238475331,106.76610808,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.7889184707,0.5118381311,1.2159945022,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,702,537,0.9802444918,0.7572855493,1.2688466915,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,3.685242666,1.6204545746,8.3809899522,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1287849511,0.8753233885,1.45563969,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,0.9775874206,0.8045698269,1.1878113408,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,14.190614018,1.8074103901,111.41549662,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.8182433458,0.527300525,1.2697164923,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,702,537,1.0373523401,0.8054005346,1.3361052436,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,3.6504312436,1.600870203,8.3240029323,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1202147982,0.8668357919,1.447657337,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,0.9495880695,0.7804754783,1.1553437961,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,13.801000506,1.7615229904,108.12666993,1,1
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.7902293387,0.5130417843,1.2171765084,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,0.9732749558,0.7591605787,1.2477783571,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,3.6623318301,1.6052532533,8.3554880866,1,1
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1278331614,0.8713368343,1.4598345783,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,0.942148851,0.7747525826,1.1457134541,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,0.4228636006,0.106630676,1.6769435535,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.688856177,0.3981648603,1.1917747643,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,702,537,0.9871642561,0.614387964,1.5861203761,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.8209785727,0.5131054017,6.4625376219,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.5380927878,1.0037854113,2.3568079366,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,0.8624695625,0.6100978444,1.2192368046,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,0.3656126782,0.0877395195,1.5235167829,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.6874304328,0.3749874924,1.2602036321,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,702,537,0.9121430348,0.5416610101,1.5360251162,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.291162966,0.3460024216,4.8181795878,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7907553619,0.4428380177,1.4120152682,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,0.7766162208,0.5275829308,1.1431999013,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,0.4154996782,0.0988243912,1.7469369713,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.7399522294,0.4008838419,1.3658053644,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,1.0486357145,0.6166366922,1.7832815915,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,1.2572058312,0.3366284457,4.6952850312,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7749653557,0.4342590261,1.3829794347,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,0.7547390748,0.5121693252,1.1121928686,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,0.3701649143,0.0889416355,1.5405840366,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,0.7206901148,0.3912804757,1.3274218212,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,702,537,0.9727470767,0.5770474851,1.6397903113,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,1.3144585499,0.3521849789,4.9059482454,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7890137306,0.4426812375,1.4063000968,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,702,1920,0.7801201048,0.530043232,1.1481844143,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,0.3689522817,0.0885111062,1.5379514737,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.6934369616,0.3789459654,1.2689271387,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,702,537,0.9366576785,0.5577379947,1.5730102934,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.2883518685,0.3452444301,4.8077547161,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7868769308,0.4406167657,1.4052468093,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,0.781705512,0.5311728066,1.1504043502,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,0.4197101809,0.099773342,1.7655681611,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.7674521526,0.4149303049,1.4194740651,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,702,537,1.1104361924,0.6539519004,1.8855645754,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.2807287045,0.342661331,4.7868430612,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7740392479,0.4348317296,1.377858874,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,0.7579125559,0.5140301717,1.1175053023,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,0.4086206106,0.097359639,1.7149899594,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.7329211192,0.396653064,1.3542650135,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,1.0567531179,0.6207051088,1.7991267293,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,1.2568247529,0.3363325368,4.6965674941,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7722803657,0.4325045547,1.3789842367,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,0.7535748507,0.5110060859,1.1112882436,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,515,132,2.9584308503,0.3896211671,22.463648887,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2723,688,1.2323052303,0.6333023421,2.3978692004,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,674,520,2.1162648294,0.8979858135,4.9873581084,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,515,657,1.2482071774,0.57799807,2.6955473357,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2585148445,0.8579242402,1.8461532378,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,674,1895,1.4967847444,0.8836621784,2.535317937,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,515,132,4.2161105286,0.5369676593,33.103647269,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2723,688,1.0537595683,0.4534425573,2.448842108,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,674,520,1.952357218,0.7796546798,4.8889576442,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,515,657,1.2170848431,0.5098607513,2.9052942624,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2066084068,0.7708709973,1.8886478445,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,674,1895,1.3649521494,0.7612638706,2.4473700145,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,515,132,4.1392673757,0.5243157951,32.677891013,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2723,688,1.0348083327,0.4420239512,2.4225571544,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,674,520,1.9900129296,0.8069658948,4.9074582772,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,515,657,1.2275121586,0.5138110063,2.932568748,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2196631041,0.7783610148,1.9111672594,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,674,1895,1.3623091349,0.7536762621,2.4624447821,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,515,132,4.2181680491,0.5373585084,33.111863703,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2723,688,1.0460508584,0.4531766638,2.4145603375,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,674,520,1.9367795577,0.770170949,4.8704966861,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,515,657,1.2149683539,0.5088598159,2.9008934385,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2078280104,0.7712054004,1.8916471562,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,674,1895,1.3648430528,0.7611306935,2.4474069625,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,515,132,4.1606341359,0.5258204396,32.921649883,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2723,688,1.0431324326,0.4488158935,2.4244356932,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,674,520,1.8572041693,0.7416761676,4.6505570451,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,515,657,1.2221848388,0.5119641984,2.9176567132,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2133897246,0.7751433842,1.8994093916,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,674,1895,1.3512262054,0.7535442127,2.4229663335,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,515,132,4.1361795462,0.519263911,32.946601675,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2723,688,1.0208862057,0.4390374864,2.3738488794,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,674,520,1.9024773865,0.7670454312,4.7186516717,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,515,657,1.2280993924,0.5138386846,2.9352171464,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.226266955,0.7822393113,1.9223409297,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,674,1895,1.3492463286,0.747070342,2.436806219,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,515,132,4.1214598974,0.5222931916,32.522789803,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2723,688,1.0287521507,0.4398396671,2.4061744917,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,674,520,1.9878058526,0.8000949343,4.9386290778,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,515,657,1.2140237443,0.5074933274,2.9041833108,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.1981155624,0.7657187348,1.8746843139,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,674,1895,1.344716047,0.7443974762,2.4291609053,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,137,107748.53528,43947.307134,264174.24894,0,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2778,705,1.1239889492,0.5200506768,2.429284711,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,680,519,1.5024708615,0.7298214818,3.0931107756,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,657,0.7689963463,0.2516798745,2.3496331672,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.3065227082,0.8495500238,2.0093008525,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,680,1900,1.8974613609,1.1561156381,3.1141864165,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,137,58467.968881,21832.934678,156575.53304,0,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2778,705,0.7443628007,0.308059041,1.7986032068,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,680,519,1.6655747703,0.7713901447,3.5962856596,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,657,0.4807358087,0.1433788428,1.611862066,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1632854778,0.7263927516,1.8629496231,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,680,1900,1.8781829711,1.0679019251,3.3032726979,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,137,65068.770076,24133.082813,175441.52448,0,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2778,705,0.7395857451,0.3024424102,1.8085660471,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,680,519,1.7401885867,0.811806137,3.7302702939,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,657,0.4845203737,0.1445025423,1.624608044,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1835845276,0.7368104788,1.9012654873,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,680,1900,1.88049988,1.0585943085,3.340542992,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,137,58422.642737,21822.416707,156408.21226,0,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2778,705,0.7516327003,0.3109342412,1.8169491851,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,680,519,1.6851947643,0.7808686298,3.6368235133,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,657,0.4822521177,0.1436391987,1.6191061146,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1619794475,0.7258712636,1.8601042694,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,680,1900,1.8780282058,1.068031075,3.3023289531,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,137,58104.87622,21695.170437,155618.81159,0,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2778,705,0.7379040308,0.3051700661,1.7842587434,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,680,519,1.6310134703,0.7580139931,3.5094404119,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,657,0.4817248802,0.1436683928,1.6152394806,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.165896072,0.7278237397,1.8676412662,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,680,1900,1.870755728,1.0647894242,3.2867785069,1,1
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,526,137,64707.970933,24012.370041,174373.52061,0,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2778,705,0.7429454441,0.3039724106,1.8158487864,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,680,519,1.7289359671,0.8088771614,3.695517343,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,526,657,0.487222637,0.1450747564,1.6363005115,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.18778954,0.7386028307,1.9101524295,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,680,1900,1.8698401202,1.0545322088,3.3155005089,1,1
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,137,66439.575622,24611.99754,179352.25297,0,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2778,705,0.748323447,0.3056209289,1.8322959205,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,680,519,1.7676296282,0.8226299414,3.7982017733,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,657,0.4781076459,0.1425493324,1.6035636034,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1646069434,0.7269402782,1.8657782124,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,680,1900,1.8620749605,1.0490769698,3.3051179833,1,1
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,2.2138649056,0.1568091338,31.25581847,1,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,11983963.312,1621393.2517,88575289.509,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs DMARD,Medicare,702,537,3167743.4063,455053.75248,22051457.071,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.6510327E-8,9.388548E-10,2.9034406E-7,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,7309439.7471,1000917.4469,53378937.078,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,0.3147931824,0.0368822043,2.6867902734,1,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,2.197677555,0.034394187,140.42450346,1,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,11802891.878,1460974.3681,95352977.935,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,702,537,3097163.7208,375300.57162,25559308.561,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,1.6339326E-8,2.253057E-10,1.1849394E-6,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,7357777.6886,1008470.6734,53682168.401,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,702,1920,0.3139339368,0.0362219322,2.7208520029,1,0
Kidney disease,Amyloidosis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,2.3680824791,0.1790163669,31.32570907,1,0
Kidney disease,Amyloidosis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,11562804.193,1281149.2135,104358211.67,0,0
Kidney disease,Amyloidosis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,702,537,2617648.6387,276951.63681,24741086.475,0,0
Kidney disease,Amyloidosis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.4886176E-8,9.629504E-10,2.3012423E-7,0,0
Kidney disease,Amyloidosis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,7212092.9274,1051420.0773,49470507.096,0,0
Kidney disease,Amyloidosis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,0.3048412988,0.0376094909,2.4708714562,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,536,138,2298902.9082,318016.04416,16618515.569,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,1219195.3398,384245.32466,3868458.9796,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,702,537,0.9932481786,0.164453656,5.9989055174,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,536,662,1.1956561051,0.0746973811,19.138469118,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.8007820784,0.1599843638,4.0082163145,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,2.6863204439,0.535311498,13.480595045,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,MPCD,536,138,4308249.0573,560321.18961,33125661.288,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,445074.17007,139740.87379,1417559.5979,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Medicare,702,537,1.5028803017,0.2489558489,9.0724890009,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,536,662,5.1168815856,0.3151390006,83.082313227,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7056312468,0.1397584132,3.562686819,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,3.556005762,0.7110453632,17.783924394,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,536,138,9063952.7673,1220523.9857,67311450.433,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,998788.65033,311411.55545,3203409.6056,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,1.2662358819,0.2202409146,7.2799975032,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,536,662,5.3552855533,0.3278266631,87.48246128,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7289951226,0.1433350296,3.7076344157,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,3.7332279815,0.7349793536,18.962425399,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,536,138,4316527.0081,554424.24878,33606764.951,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,432316.95869,136210.52804,1372125.6019,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,702,537,1.4569981925,0.226053485,9.39089142,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,536,662,5.0897950711,0.3156830538,82.063365637,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7073657367,0.1401132316,3.5711565546,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,702,1920,3.5498485056,0.7069664906,17.824641735,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,536,138,4274013.7555,557207.83719,32783446.97,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,441147.94774,136369.87729,1427085.7734,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,702,537,1.4752725944,0.2470964613,8.8080145569,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,536,662,5.1249304531,0.3155532448,83.234486046,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7074329545,0.140710103,3.5566840924,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,3.5431472775,0.7107510894,17.662853871,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,536,138,9077719,1191293.3113,69172706.221,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,975565.79692,300106.73141,3171300.4892,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,702,537,1.2219786702,0.1972815997,7.5690377249,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,536,662,5.3264331412,0.3303411485,85.883608907,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7309500624,0.144447104,3.6988487763,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,3.699348338,0.7196559086,19.016279812,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,536,138,9236680.2945,1253755.2279,68048579.948,0,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,1032212.6336,318926.3808,3340780.146,0,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,1.3180452831,0.2268781237,7.6571656172,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,536,662,5.478173613,0.336102542,89.289375655,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.750047238,0.1477478941,3.8076404598,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,3.7868980872,0.752044572,19.06881275,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,4212774.5771,1011298.8864,17549183.407,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2818,710,0.3945735576,0.0352843212,4.4123930108,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,702,537,1.3780168333,0.1275066633,14.892793399,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,4182724.0973,1024805.4028,17071710.225,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.7126084023,0.1523540126,19.251396723,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,1.9100574617,0.3290928058,11.085989855,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,2630828.9397,607646.70544,11390271.432,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2818,710,0.5416437308,0.0482141153,6.0848971189,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,702,537,2.465297794,0.1988550027,30.563441359,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,2618062.5526,615562.25784,11134944.422,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.7619108873,0.1573243633,19.732035838,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,3.2003134717,0.4538168977,22.568587397,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,2344686.5333,458113.06256,12000432.62,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2818,710,0.4871320913,0.0460517426,5.1528489731,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,2.3242368163,0.2023777834,26.693032635,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,2564954.974,622221.48777,10573395.725,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.8667339186,0.159228714,21.884843734,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,3.2742046935,0.4502682886,23.808952674,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,2620841.3449,595787.59136,11528956.72,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2818,710,0.5470708505,0.0498050619,6.0091585926,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,702,537,2.5050446485,0.1755787471,35.740366051,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,2622652.4109,619345.81637,11105759.475,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.7594735314,0.1569856285,19.719939572,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,702,1920,3.2040965493,0.4493848428,22.845084479,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,2661596.2773,614624.20404,11525896.144,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2818,710,0.5464682848,0.0485914614,6.1456802881,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,702,537,2.5261766485,0.226705499,28.149156012,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,2627689.3226,617650.1315,11179065.338,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.7589497963,0.1570380461,19.701623032,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,3.2115819129,0.4613552584,22.356433997,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,2381792.3908,445784.43287,12725735.972,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2818,710,0.4937056135,0.0477171939,5.1081216781,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,702,537,2.46492468,0.2136729018,28.435302874,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,2604957.3957,634604.95741,10692956.231,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.857343663,0.1588772562,21.713148654,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,3.3319695622,0.4662326603,23.812191012,1,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,5096819.573,917605.13697,28310183.447,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2818,710,0.5150616551,0.0498374757,5.3230727486,1,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,2.5722184443,0.2237291892,29.572840931,1,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,5677009.4183,1387808.4867,23222538.445,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.9165789746,0.1594253406,23.040722078,1,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,3.2115115277,0.4360925419,23.650499152,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,1.0186606421,0.8151347641,1.273003618,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2818,710,0.551694483,0.0572237181,5.3188924579,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,699,533,0.8975106033,0.3787647806,2.1267164329,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.9933220412,0.8728887593,1.130371616,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2818,2651,2991301.6624,962596.2108,9295575.3772,0,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,699,1916,2.5546866811,1.1695206164,5.5804266698,1,1
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,1.0686607074,0.8069339803,1.4152777495,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2818,710,0.8716251202,0.0873865507,8.6939047753,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,699,533,0.8077471362,0.3268630895,1.9961123086,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.0297558857,0.8544240112,1.2410666956,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2818,2651,1745298.4822,525150.40256,5800370.2884,0,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,699,1916,2.3324572234,1.0194327892,5.3366506913,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,1.8012010563,1.282373326,2.5299381851,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2818,710,0.986567954,0.0996804184,9.7643684057,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,699,533,0.9449197881,0.3746661458,2.3831173859,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,1.5210773755,1.2349224546,1.8735398111,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1148973.9806,341458.14489,3866187.4899,0,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,699,1916,2.1927865995,0.9618086349,4.9992409058,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,1.0710922345,0.8096453418,1.4169643368,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2818,710,0.8979310842,0.0896882007,8.9898138879,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,699,533,0.8410404657,0.3340983608,2.1171880734,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,1.0400153635,0.8647650023,1.2507813722,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1737964.0725,522469.10272,5781239.6973,0,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,699,1916,2.3412289041,1.0235301007,5.3553410669,1,1
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,1.0454092032,0.7881207555,1.3866915629,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2818,710,0.8904653593,0.0892285381,8.8864904978,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,699,533,0.8512365211,0.343040235,2.1122992024,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.0375613213,0.8607733172,1.2506585344,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1916443.1876,576406.37826,6371814.4519,0,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,699,1916,2.3630482193,1.0323715714,5.408902222,1,1
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,1.7714091186,1.2559190235,2.4984813564,1,1
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2818,710,1.0056884694,0.1014498091,9.969553477,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,699,533,0.9899432443,0.390293723,2.5108977399,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.5348108623,1.2431000396,1.8949757125,1,1
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1256770.5102,373515.21774,4228668.7137,0,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,699,1916,2.2060836233,0.9682338132,5.0264769589,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,1.2775337374,0.8947465052,1.8240836266,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2818,710,0.9844003028,0.1009967646,9.5948019744,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,699,533,0.9420013664,0.3715915773,2.3880158443,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,0.9106164554,0.7391964975,1.1217887689,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1243468.1307,369573.03474,4183781.9505,0,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,699,1916,2.198670457,0.9633983512,5.01781197,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,534,139,85428.568248,31577.010677,231118.78282,0,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2804,704,1.1049727296,0.3842078017,3.1778759515,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,681,516,1.3351897814,0.7982750993,2.2332298152,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,534,662,0.4858566377,0.1526519091,1.5463722252,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2804,2643,0.9355365791,0.5219472236,1.6768528524,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,681,1888,0.9959107783,0.7024774592,1.4119147388,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,534,139,62835.46792,20411.949435,193430.61971,0,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2804,704,1.0133368848,0.3157542526,3.2520595798,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,681,516,1.3917612093,0.7983033399,2.4263950392,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,534,662,0.4045198316,0.1124795277,1.4548095781,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2804,2643,1.021403346,0.5079448617,2.0538937866,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,681,1888,1.0532923073,0.7056551122,1.5721910965,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,534,139,67503.140113,21951.847912,207575.86985,0,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2804,704,1.0629024699,0.330544427,3.4178814348,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,681,516,1.4918444242,0.861464273,2.5835079361,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,534,662,0.399277992,0.1108182356,1.4385982055,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2804,2643,1.0143163918,0.5023614296,2.0480030554,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,681,1888,1.0307163514,0.6861889663,1.5482268724,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,534,139,62821.34746,20410.890892,193353.7207,0,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2804,704,0.997951695,0.3096640018,3.2160909241,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,681,516,1.3658389585,0.7868493639,2.3708681054,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,534,662,0.402875408,0.1120801826,1.4481471272,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2804,2643,1.0222917806,0.5083418684,2.0558615168,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,681,1888,1.051617498,0.7049390266,1.5687872571,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,534,139,65074.687539,21114.471262,200559.83906,0,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2804,704,1.0242792827,0.3191970802,3.2868347295,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,681,516,1.4524563189,0.8089457529,2.607874942,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,534,662,0.4029544542,0.1120474038,1.4491392633,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2804,2643,1.0180995912,0.5062891743,2.0473018786,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,681,1888,1.0648333701,0.706462974,1.6049958001,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,534,139,69731.20544,22674.236607,214447.83771,0,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2804,704,1.0505989342,0.3257330708,3.3885356431,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,681,516,1.5052067163,0.8536130506,2.6541853563,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,534,662,0.3962872573,0.1100760383,1.4266827986,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2804,2643,1.0124410921,0.5016751766,2.0432283933,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,681,1888,1.0398614303,0.6852589989,1.5779607361,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,534,139,34657.777951,11363.910758,105699.66608,0,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2804,704,1.0337198859,0.3226188878,3.3121954199,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,681,516,1.4790419318,0.8509805217,2.5706405495,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,534,662,0.3985257534,0.1106807029,1.434963566,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2804,2643,1.0125223967,0.5005624466,2.0480993147,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,681,1888,1.0241204471,0.6807645763,1.5406540331,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,1.0226161588,0.0002367833,4416.458855,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,2744191.9262,396430.58803,18995984.556,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,701,537,0.6751918975,0.0422536827,10.78921573,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,8.2208835E-8,1.507353E-11,0.0004483549,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2650,2736616.5331,392269.33934,19091652.848,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,701,1919,0.6898318288,0.0795138966,5.9847142747,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,1.020585629,1.020585629,1.020585629,1,1
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,6028039.8932,898292.89977,40451466.291,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,701,537,0.4414157383,0.0277676391,7.0170839214,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.0410871E-7,2.1284218E-8,5.0923291E-7,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2650,6030013.4819,877778.13448,41423978.525,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,701,1919,0.3670994607,0.0422223214,3.1917244171,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,0.8856180022,0.4094201549,1.9156830371,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,5529355.2626,893379.29227,34222608.342,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,701,537,0.376293161,0.0192947178,7.3386169531,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,1.030723E-7,1.3033532E-8,8.1512048E-7,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2650,6192578.1906,863237.91551,44423471.164,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,701,1919,0.3796237405,0.0461754562,3.1210126791,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,1.0573206991,1.0573206991,1.0573206991,1,1
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,6466234.6321,873632.82774,47860140.999,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,701,537,0.4747758362,0.0275718502,8.1754431724,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,1.0741154E-7,1.7413918E-8,6.625298E-7,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2650,6004533.2185,878330.9657,41048785.231,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,701,1919,0.367343779,0.0421395903,3.2022487846,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,0.9951421842,0.9951421842,0.9951421842,1,1
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,5924280.5351,883467.1173,39726549.151,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,701,537,0.415596395,0.0261415072,6.6071310369,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.0057772E-7,3.2558105E-8,3.1070226E-7,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2650,6272002.0556,911720.40364,43147010.452,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,701,1919,0.3625777498,0.0417410613,3.149479685,1,0
Neurological Disease,Cauda Equina syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,0.844223542,0.844223542,0.844223542,1,1
Neurological Disease,Cauda Equina syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,5728372.4013,941808.42649,34841746.415,0,0
Neurological Disease,Cauda Equina syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,701,537,0.3654709524,0.0193962569,6.886329557,1,0
Neurological Disease,Cauda Equina syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,9.6307134E-8,1.4321332E-8,6.4763976E-7,0,0
Neurological Disease,Cauda Equina syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2650,6627238.2476,882897.30502,49745634.675,0,0
Neurological Disease,Cauda Equina syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,701,1919,0.3776472994,0.045003935,3.1690002847,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,0.9980214382,0.9980214382,0.9980214382,1,1
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2817,709,1.8460818004,0.2365218198,14.408894777,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,701,536,0.6654999295,0.0938280563,4.7202315971,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.3451779E-6,1.9276106E-7,9.387288E-6,0,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.8978192495,0.3659286343,2.2028322715,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,701,1918,0.4156068828,0.093619664,1.8450085565,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,0.9917206363,0.7690597642,1.2788470628,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2817,709,1.6216568738,0.2068313101,12.714569254,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Medicare,701,536,0.6459152693,0.0822537326,5.0721896986,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.2206134E-6,1.7218271E-7,8.6530005E-6,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.5864591759,0.2276846292,1.5105734901,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,701,1918,0.3512352634,0.0696080888,1.7722970478,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,0.977997689,0.6908804424,1.3844355998,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,709,1.6679389908,0.2079057807,13.381159813,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,701,536,0.6754658926,0.0882174995,5.1719236506,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,1.2088375E-6,1.6767056E-7,8.7152339E-6,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.5946573983,0.229532557,1.5405981005,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,701,1918,0.3481448754,0.0681952055,1.7773222245,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,0.9931915528,0.7518500742,1.3120028772,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2817,709,1.6405303543,0.2067419389,13.017870771,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,701,536,0.6556992199,0.0802794792,5.3555587475,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,1.2254678E-6,1.7285827E-7,8.6878764E-6,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.5859905736,0.2272843775,1.5108163443,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,701,1918,0.351563482,0.0694860443,1.7787295717,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,0.9804830646,0.7421678735,1.2953228971,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2817,709,1.604618034,0.2045450316,12.587932421,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,701,536,0.6257208621,0.0799437169,4.8975280648,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.2174146E-6,1.7118341E-7,8.6579551E-6,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.5892453794,0.2287300122,1.5179910755,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,701,1918,0.3493120422,0.0693972293,1.7582676438,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,0.9692380558,0.6866747368,1.3680748082,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2817,709,1.6768556812,0.2073018723,13.564011481,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,701,536,0.6709075859,0.0842748095,5.3410620758,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.2101511E-6,1.6870776E-7,8.6804884E-6,0,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.5978622557,0.2306257107,1.5498674265,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,701,1918,0.3471093969,0.067910398,1.7741750459,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,1.0032760808,0.7043995822,1.4289657741,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,709,1.6419204305,0.2048962924,13.157401089,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,701,536,0.6537164418,0.0845835216,5.0523456373,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,1.1162045E-6,1.5542142E-7,8.0163501E-6,0,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.583376112,0.2263001872,1.5038771835,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,701,1918,0.3479970259,0.0682995724,1.7730993891,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,535,138,103600.19301,37981.85125,282582.32918,0,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2814,708,2.7399457857,0.3624188065,20.714440791,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,693,521,0.849221471,0.5368909476,1.3432469107,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,535,662,0.8034625,0.2261756135,2.854206865,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.5253562855,0.2746550474,1.0048940635,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,693,1896,0.9689271705,0.6820814524,1.3764043259,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,535,138,38555.213875,12147.439458,122371.83994,0,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2814,708,7.9091911144,1.0041272457,62.298184173,1,1
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,693,521,0.8251156199,0.4957917121,1.3731891226,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,535,662,0.9346934592,0.232548138,3.7568645791,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.8200434254,0.3774163392,1.7817755876,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,693,1896,0.9780876679,0.6574897568,1.4550119999,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,535,138,39095.812336,12134.278288,125964.02571,0,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2814,708,7.888238001,1.0018548967,62.109092807,1,1
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,693,521,0.8314604093,0.5062969312,1.3654564539,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,535,662,0.9355427464,0.2334945252,3.7484400522,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.8208186703,0.3779315567,1.7827124451,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,693,1896,0.9689039097,0.6432328518,1.4594633708,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,535,138,38515.217057,12138.600576,122206.99872,0,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2814,708,8.0641105964,1.0242994597,63.487175646,1,1
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,693,521,0.8481827083,0.5052746132,1.4238077429,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,535,662,0.9407885368,0.2341904343,3.7793305847,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.8195308493,0.3770539583,1.7812591496,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,693,1896,0.980498906,0.6587657464,1.4593626186,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,535,138,38570.900857,12152.794657,122417.47144,0,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2814,708,7.9125642376,1.0046314633,62.320039835,1,1
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,693,521,0.8262752033,0.4972412104,1.3730372652,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,535,662,0.9345799409,0.2325166495,3.7564607426,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.8198967577,0.377291982,1.7817253625,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,693,1896,0.9782610246,0.6582137821,1.4539267609,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,535,138,38997.408499,12097.832642,125708.29129,0,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2814,708,8.0296426126,1.0203909723,63.186721793,1,1
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,693,521,0.8520993399,0.5145667123,1.4110381954,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,535,662,0.9421770474,0.2353188744,3.7723178431,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.8209186911,0.3777791312,1.7838663963,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,693,1896,0.9714353182,0.6445728308,1.4640495726,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,535,138,49565.337317,15018.07011,163584.44496,0,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2814,708,7.7754441163,0.9894114608,61.10453901,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,693,521,0.8115713091,0.4921136494,1.3384062613,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,535,662,0.9311707182,0.2320625595,3.736401547,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.8120811911,0.3763024909,1.7525152684,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,693,1896,0.9739714327,0.6462671239,1.4678455959,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,534,138,1.0943577791,0.2404605085,4.9805223993,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2803,705,1.1919996873,0.5386823508,2.6376643902,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,685,511,0.8315332933,0.5434629591,1.2722994386,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,534,658,0.6608004953,0.3053180887,1.4301717155,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.1561370785,0.7373308618,1.8128265254,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,685,1879,0.9227854596,0.6671363553,1.2764002408,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,534,138,1.5009133536,0.2796280402,8.056205283,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2803,705,1.9993107907,0.8373382995,4.773749917,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,685,511,0.7781114188,0.4845185724,1.249606134,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,534,658,1.0601685862,0.3724329948,3.017878241,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.5827813702,0.9320912205,2.6877164069,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,685,1879,0.8559293385,0.5867425203,1.2486141829,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,534,138,1.4716520679,0.2755087755,7.8609467333,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2803,705,1.9872419718,0.8300749564,4.7575590908,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,685,511,0.7783415948,0.4896139747,1.2373332249,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,534,658,1.0677465306,0.374494263,3.044326085,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.6013031476,0.9418193632,2.7225727892,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,685,1879,0.8581455122,0.5865968332,1.2554000949,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,534,138,1.5066656159,0.2801230588,8.1037287245,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2803,705,2.0638965686,0.8610854087,4.9468600943,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,685,511,0.8111106027,0.5035164191,1.3066116314,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,534,658,1.070976242,0.3755998959,3.0537551353,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.5804425215,0.9304560407,2.6844885247,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,685,1879,0.8577914015,0.5880970825,1.2511643237,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,534,138,1.523613691,0.2836858077,8.182991946,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2803,705,2.0425981386,0.8542689786,4.883950208,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,685,511,0.8109675125,0.5002080672,1.3147894837,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,534,658,1.0555592656,0.3707976972,3.0048874944,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.5743502578,0.9281321331,2.6705020176,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,685,1879,0.8665576043,0.5925998005,1.2671655997,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,534,138,1.4733366685,0.2750357891,7.892503539,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2803,705,2.0666384659,0.8601917527,4.9651656567,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,685,511,0.8295034343,0.5165046825,1.3321775599,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,534,658,1.0766003241,0.3770971405,3.073659631,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.592189199,0.9375369496,2.7039643041,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,685,1879,0.872699872,0.5942852375,1.2815480151,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,534,138,1.450135663,0.2751866661,7.6416981626,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2803,705,1.9480372318,0.8121462297,4.6726179565,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,685,511,0.7742934847,0.4853996717,1.2351273299,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,534,658,1.0651466445,0.3745569321,3.0290118189,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.5840809462,0.929865672,2.6985752027,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,685,1879,0.8605699371,0.5885431981,1.258328393,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,531,137,2.9125847693,0.3850509,22.031243244,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2749,693,1.2343589274,0.6733305592,2.2628439197,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,681,515,1.6548985518,0.8658006117,3.1631869739,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,531,659,1.9771909371,0.8195870455,4.7698216113,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.5687920098,1.0803845675,2.2779928963,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,681,1889,1.6067401738,1.0380520821,2.4869792474,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,MPCD,531,137,3.8475172329,0.4857641389,30.474437429,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2749,693,0.8760760573,0.4430141635,1.7324711523,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Medicare,681,515,1.385584096,0.6980611601,2.7502508331,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,531,659,1.1612209926,0.4205294845,3.2065152226,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.5035463384,0.9880350178,2.2880278038,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,681,1889,1.1313469637,0.6913445623,1.8513864461,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,531,137,4.0184006092,0.5050743425,31.970627089,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2749,693,0.9006828812,0.4575482731,1.7729924908,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,681,515,1.4187574331,0.7193470851,2.7981939396,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,531,659,1.1475296533,0.4158894536,3.1662844387,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.483925412,0.9738269199,2.2612176594,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,681,1889,1.1232511355,0.6825043414,1.8486228394,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,531,137,3.8466327442,0.4863189209,30.425679185,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2749,693,0.888486804,0.4484913177,1.7601428826,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,681,515,1.4126081181,0.7160591846,2.786727324,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,531,659,1.1669066919,0.4228650019,3.2201085962,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.501540319,0.986808684,2.2847623517,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,681,1889,1.1316370449,0.6916441494,1.8515336283,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,531,137,3.8041981581,0.4803067518,30.130585449,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2749,693,0.8651925906,0.4376175839,1.7105304869,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,681,515,1.3407573947,0.6780453116,2.6511950758,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,531,659,1.1642732478,0.4216121572,3.2151164821,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.5091249941,0.9916882816,2.2965464956,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,681,1889,1.1214312054,0.6859160745,1.833472046,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,531,137,3.9894180152,0.5018193494,31.715509013,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2749,693,0.9022847756,0.4575290567,1.7793794829,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,681,515,1.4046732947,0.7172725086,2.7508471905,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,531,659,1.1560164497,0.419180356,3.1880645473,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.4857215152,0.9748856997,2.2642330495,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,681,1889,1.1118364833,0.676112779,1.8283641488,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,531,137,3.9678449875,0.4977425846,31.630393568,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2749,693,0.8940756237,0.4545430393,1.7586260305,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,681,515,1.4300449635,0.7233693224,2.8270878157,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,531,659,1.1289024069,0.4082155812,3.1219304284,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.459041449,0.9575822117,2.2231009765,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,681,1889,1.1090946927,0.6743037003,1.8242388955,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,519,135,1.8190725285,0.421384537,7.8527439271,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2705,686,0.8732671957,0.5241442648,1.4549345405,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,669,503,2.8391208982,1.3096329083,6.154860208,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,519,656,2.198997401,0.9754333544,4.9573756607,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0698751731,1.3882882615,3.0860905122,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,669,1883,2.3822763581,1.5058822714,3.7687146958,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,MPCD,519,135,4.0789616729,0.8069388786,20.618573189,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2705,686,0.7651169169,0.4179362431,1.4007014378,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Medicare,669,503,2.4934757488,1.103967635,5.6318873061,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,519,656,3.3079211715,1.1038464239,9.9129210729,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0280766687,1.2936898597,3.1793516379,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,669,1883,1.9097755983,1.1509314782,3.1689487211,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,519,135,4.2636868528,0.8486110534,21.422093792,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2705,686,0.7917506601,0.4354334353,1.4396439433,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,669,503,2.6706359337,1.1820061206,6.0340603707,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,519,656,3.2632359629,1.0840145383,9.8234004925,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0218784959,1.2894164966,3.1704206228,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,669,1883,1.8741501671,1.1252127845,3.1215774451,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,519,135,4.0918204044,0.8106745553,20.653163605,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2705,686,0.7857102067,0.4293246262,1.4379341209,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,669,503,2.5901266624,1.1465362067,5.8513251372,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,519,656,3.3366519042,1.1169316153,9.9677059701,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0214746286,1.2899715886,3.1677904461,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,669,1883,1.9128494938,1.152868075,3.1738177727,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,519,135,4.0549043626,0.8022275834,20.495741771,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2705,686,0.7602607355,0.4150814484,1.3924890842,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,669,503,2.44754631,1.0809768346,5.5417310971,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,519,656,3.3124287818,1.1053024657,9.9268614472,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0310598879,1.2955442576,3.1841477001,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,669,1883,1.9010982224,1.1450322103,3.1563954436,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,519,135,4.2477179443,0.846176754,21.323095499,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2705,686,0.8035343835,0.441694478,1.4617966437,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,669,503,2.6981574494,1.1913764404,6.1106241274,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,519,656,3.3005018875,1.0999759313,9.9032282432,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0233762493,1.2903294778,3.1728729107,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,669,1883,1.8611680469,1.1159614235,3.1040020073,1,1
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,519,135,4.2162936087,0.8390973296,21.186018794,1,0
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2705,686,0.7840338033,0.4313371761,1.4251240996,1,0
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,669,503,2.7015318833,1.1932687255,6.1162036349,1,1
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,519,656,3.2376557119,1.0700340617,9.7963372234,1,1
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0035416668,1.2766870312,3.144215546,1,1
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,669,1883,1.8517124488,1.1102585818,3.0883246921,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,506,130,0.7467302932,0.2771935995,2.0116125756,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2648,666,1.3737344931,0.8390789896,2.2490688971,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,667,507,1.8047490905,0.9945118826,3.2750933765,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,506,640,0.6062034355,0.3392802148,1.0831241822,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9039884673,0.7045376511,1.1599027357,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,667,1869,1.4254291194,0.9714452739,2.0915724528,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,506,130,0.6576259584,0.202269878,2.13809345,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2648,666,1.5944490124,0.9315401762,2.7291014581,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,667,507,2.0085007057,1.0658551258,3.7848249609,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,506,640,0.5625131665,0.2899745679,1.0912028068,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9569450258,0.7209638426,1.270166031,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,667,1869,1.4211769467,0.9204934257,2.1941970008,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,506,130,0.6677325264,0.2043892604,2.1814586824,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2648,666,1.6129611022,0.9419451389,2.7619904917,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,667,507,2.0080009981,1.0696938534,3.7693663432,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,506,640,0.5606613188,0.2888778589,1.0881454037,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9576090879,0.7203555861,1.2730034762,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,667,1869,1.4250635769,0.9208765846,2.205296814,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,506,130,0.6572284382,0.2022581374,2.1356333321,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2648,666,1.5761862948,0.9199484751,2.7005460664,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,667,507,1.9793416378,1.0466789401,3.7430707441,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,506,640,0.5605839668,0.2887846496,1.0881962886,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9575317153,0.7216039125,1.2705959182,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,667,1869,1.4197823001,0.919155369,2.1930805691,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,506,130,0.6472297882,0.1990032391,2.1050230167,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2648,666,1.5656150937,0.9147288587,2.6796471963,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,667,507,1.9213477225,1.0205786875,3.6171410551,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,506,640,0.5643549248,0.2909119238,1.0948209926,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9627589544,0.7250891618,1.2783321737,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,667,1869,1.411833492,0.9147404403,2.179059459,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,506,130,0.662533631,0.2028037486,2.1644117293,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2648,666,1.5781231696,0.9206755215,2.705049369,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,667,507,1.9108819713,1.0149720243,3.5976064569,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,506,640,0.5598055968,0.2882346073,1.0872473265,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9623434374,0.7235358032,1.2799710636,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,667,1869,1.4120389362,0.9126842532,2.1846043147,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,506,130,0.6612031112,0.202403411,2.1599910402,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2648,666,1.5992825798,0.934282232,2.7376146977,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,667,507,2.0084787768,1.0673083349,3.7795891448,1,1
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,506,640,0.5545496765,0.2855576395,1.0769291422,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9437277063,0.7100509692,1.2543071164,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,667,1869,1.4105631668,0.9100697383,2.1863032732,1,0
